Approval · Notice of Compliance 14632 · 2013
RATIO-VALPROIC: Notice of Compliance 14632
Issued August 8, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14632
- Date
- August 8, 2013
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative merger/buyout
- Therapeutic class
- Antiepileptic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RATIO-VALPROIC | 02217414 | Cancelled Post Market |
| RATIO-VALPROIC | 02231489 | Cancelled Post Market |
Medicinal ingredients
- VALPROIC ACID 250 MG per CAP
- VALPROIC ACID 500 MG per CAP